Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

US Patent 8541403 · Granted Sep 24, 2013

Estimated economic value: $103,907,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

On list construction of coded information of inter prediction2025
Tether manage system for optical fiber remote control submersible2025
Decoding with signaling of segmentation information2025
Encoder, a decoder, and corresponding methods for transform process in video cod2025
Encoder, decoder and corresponding methods about signaling high level syntax2025
Encoder, a decoder and corresponding methods for inter-prediction2025
Systems and methods for window error estimation improvement in temporal filter2025
Different ranges for clipping processes for video and image compression2025
Encoder, decoder and corresponding methods for improved compression ratios2025
Database system update method and related apparatus2025
Encoder, a decoder and corresponding methods of deblocking filter adaptation2025
Adaptive range for clipping processes for video and image compression2025